Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daza Buitrago, Jorge"'
Autor:
Daza Buitrago, Jorge
Publikováno v:
Fox AN, Brown RS. Is the patient a candidate for liver transplantation? Clin Liver Dis. Elsevier Inc; mayo de 2012;16(2):435-48.
Matesanz R. Trasplante Iberoamérica Newsletter 2013. Newsl Transpl [Internet]. 2013;7(1). Recuperado a partir de: http://www.ont.es/infesp/Memorias/Memoria trasplante hepatico 2013.pdf
J MA, Et DG, Jasseron C, Di M, Mtn F, Ricci A, et al. International Figures on Donation and Transplantation-2013 NEWSLETTER TRANSPLANT. Newsl Transpl. 2014;19(1). Recuperado a partir de: http://www.ont.es/publicaciones/Documents/NEWSLETTER 2014.pdf4.
Salud IN de. Informe Anual de la Red de Donación y Trasplantes 2013, del Instituto Nacional de Salud. 2013;3. Recuperado a partir de: http://www.ins.gov.co/lineas-deaccion/ Red-Nacional-Laboratorios/Estadsticas/INFORME ANUAL 2013 RED DE DONACION Y TRASPLANTES. Vol 03.pdf
Alqahtani S a. Update in liver transplantation. Curr Opin Gastroenterol. mayo de 2012;28(3):230-8.
Winston DJ, Emmanouilides C, Busuttil RW. Infections in Liver Transplant Recipients. Clin Infect Dis. 1 de noviembre de 1995;21(5):1077-91.
Patel R, Paya C V. Infections in Solid-Organ Transplant Recipients. Clin Microbiol Rev. 1997;10(1):86-124.
Vera A, Contreras F, Guevara F. Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundación Santa Fe de Bogotá, Colombia. Transpl Infect Dis. diciembre de 2011;13(6):608-15.
Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 25 de marzo de 2014;59(3):1144-65.
Zarrinpar A, Busuttil RW. Liver transplantation: past, present and future. Nat Rev 48 Gastroenterol Hepatol. Nature Publishing Group; julio de 2013;10(7):434-40.
Arbeláez Gómez A, Velásquez Ospina M. Cirugía. Trasplantes. En: Olarte Serna F, editor. Primera ed. Medellín, Col.: Editorial Universidad de Antioquia; 2005. p. 8-9.
Fleming KM, Aithal GP, Card TR, West J. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int. enero de 2012;32(1):79-84.
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. enero de 2006;44(1):217-31.
Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. European Association for the Study of the Liver; junio de 2011;54(6):1297-306.
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. Febrero de 2001;33(2):464-70.
O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. mayo de 2008;134(6):1764-76.
Koffron A, Stein J a. Liver transplantation: indications, pretransplant evaluation, surgery, and posttransplant complications. Med Clin North Am. julio de 2008;92(4):861-88, ix.
Laish I, Braun M, Mor E, Sulkes J. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver. 2011;15-22.
Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int. octubre de 2010;30(9):1247-58.
Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Fever in Liver Transplant Recipients: Changing Spectrum of Etiologic Agents. Clin Infect Dis. enero de 1998;26(1):59-65.
Fishman J. Infection in solid-organ transplant recipients. N Engl J Med. 2007;2601-14.
Rubin RH. Preemptive Therapy in Inmunocompromised Host. N Engl J Med. 1991;324(15):1057-8.
Avery RK. Prophylactic strategies before solid-organ transplantation. Curr Opin Infect Dis. agosto de 2004;17(4):353-6.
Kim S Il. Bacterial infection after liver transplantation. World J Gastroenterol. 2014;20(20):6211-20.
Varghese J, Gomathy N, Rajashekhar P, Venugopal K, Olithselvan A, Vivekanandan S, et al. Perioperative Bacterial Infections in Deceased Donor and Living Donor Liver Transplant Recipients. J Clin Exp Hepatol. INASL; 2012;2 1(1):35-41.
Dorschner P, McElroy LM, Ison MG. Nosocomial infections within the first month of solid organ transplantation. Transpl Infect Dis. 2014;(5):1-17.
Horan TC, Andrus M, Dudeck M a. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32.
Mayo Moldes M, Galán Torres J, Moreno Gázquez A, Llacer Borras F, Moreno Puigdollers I. Prevalencia y factores de riesgo asociados a la infección en el postoperatorio inmediato del trasplante hepático. Preval risk factors early Postoper Infect after liver Transplant. 2005;52 (4):200-7.
Hsin-Yun Sun, Thomas V. Cacciarelli NS. Impact of Pretransplant Infections on Clinical Outcomes of Liver Transplant Recipients. Liver Transplant. 2010;16(3):222-8.
Kawecki D, Chmura a, Pacholczyk M, Łagiewska B, Adadynski L, Wasiak D, et al. Etiological agents of bacteremia in the early period after liver transplantation. Transplant Proc. 2007;39(9):2816-21.
García-Prado E, Cordero E, María Álamo J, Ángel Gómez M, Manuel Pascasio J, Sánchez M, et al. Estudio descriptivo de las complicaciones infecciosas en 109 receptores de trasplantes hepáticos consecutivos. Enferm Infecc Microbiol Clin. 2009;27(4):199-205.
Losada I, Cuervas-mons V, Millán I, Dámaso D. Infección precoz en el paciente con 50 trasplante hepático : incidencia, gravedad, factores de riesgo y sensibilidad antibiótica de los aislados bacterianos. 2014;20(9):422-30.
Kim Y, Kim S, Wie S. Infectious complications in living-donor liver transplant recipients: A 9-year single-center experience. Transpl Infect Dis. 2008;10(5):316-24.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Matesanz R. Trasplante Iberoamérica Newsletter 2013. Newsl Transpl [Internet]. 2013;7(1). Recuperado a partir de: http://www.ont.es/infesp/Memorias/Memoria trasplante hepatico 2013.pdf
J MA, Et DG, Jasseron C, Di M, Mtn F, Ricci A, et al. International Figures on Donation and Transplantation-2013 NEWSLETTER TRANSPLANT. Newsl Transpl. 2014;19(1). Recuperado a partir de: http://www.ont.es/publicaciones/Documents/NEWSLETTER 2014.pdf4.
Salud IN de. Informe Anual de la Red de Donación y Trasplantes 2013, del Instituto Nacional de Salud. 2013;3. Recuperado a partir de: http://www.ins.gov.co/lineas-deaccion/ Red-Nacional-Laboratorios/Estadsticas/INFORME ANUAL 2013 RED DE DONACION Y TRASPLANTES. Vol 03.pdf
Alqahtani S a. Update in liver transplantation. Curr Opin Gastroenterol. mayo de 2012;28(3):230-8.
Winston DJ, Emmanouilides C, Busuttil RW. Infections in Liver Transplant Recipients. Clin Infect Dis. 1 de noviembre de 1995;21(5):1077-91.
Patel R, Paya C V. Infections in Solid-Organ Transplant Recipients. Clin Microbiol Rev. 1997;10(1):86-124.
Vera A, Contreras F, Guevara F. Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundación Santa Fe de Bogotá, Colombia. Transpl Infect Dis. diciembre de 2011;13(6):608-15.
Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 25 de marzo de 2014;59(3):1144-65.
Zarrinpar A, Busuttil RW. Liver transplantation: past, present and future. Nat Rev 48 Gastroenterol Hepatol. Nature Publishing Group; julio de 2013;10(7):434-40.
Arbeláez Gómez A, Velásquez Ospina M. Cirugía. Trasplantes. En: Olarte Serna F, editor. Primera ed. Medellín, Col.: Editorial Universidad de Antioquia; 2005. p. 8-9.
Fleming KM, Aithal GP, Card TR, West J. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int. enero de 2012;32(1):79-84.
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. enero de 2006;44(1):217-31.
Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. European Association for the Study of the Liver; junio de 2011;54(6):1297-306.
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. Febrero de 2001;33(2):464-70.
O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. mayo de 2008;134(6):1764-76.
Koffron A, Stein J a. Liver transplantation: indications, pretransplant evaluation, surgery, and posttransplant complications. Med Clin North Am. julio de 2008;92(4):861-88, ix.
Laish I, Braun M, Mor E, Sulkes J. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver. 2011;15-22.
Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int. octubre de 2010;30(9):1247-58.
Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Fever in Liver Transplant Recipients: Changing Spectrum of Etiologic Agents. Clin Infect Dis. enero de 1998;26(1):59-65.
Fishman J. Infection in solid-organ transplant recipients. N Engl J Med. 2007;2601-14.
Rubin RH. Preemptive Therapy in Inmunocompromised Host. N Engl J Med. 1991;324(15):1057-8.
Avery RK. Prophylactic strategies before solid-organ transplantation. Curr Opin Infect Dis. agosto de 2004;17(4):353-6.
Kim S Il. Bacterial infection after liver transplantation. World J Gastroenterol. 2014;20(20):6211-20.
Varghese J, Gomathy N, Rajashekhar P, Venugopal K, Olithselvan A, Vivekanandan S, et al. Perioperative Bacterial Infections in Deceased Donor and Living Donor Liver Transplant Recipients. J Clin Exp Hepatol. INASL; 2012;2 1(1):35-41.
Dorschner P, McElroy LM, Ison MG. Nosocomial infections within the first month of solid organ transplantation. Transpl Infect Dis. 2014;(5):1-17.
Horan TC, Andrus M, Dudeck M a. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32.
Mayo Moldes M, Galán Torres J, Moreno Gázquez A, Llacer Borras F, Moreno Puigdollers I. Prevalencia y factores de riesgo asociados a la infección en el postoperatorio inmediato del trasplante hepático. Preval risk factors early Postoper Infect after liver Transplant. 2005;52 (4):200-7.
Hsin-Yun Sun, Thomas V. Cacciarelli NS. Impact of Pretransplant Infections on Clinical Outcomes of Liver Transplant Recipients. Liver Transplant. 2010;16(3):222-8.
Kawecki D, Chmura a, Pacholczyk M, Łagiewska B, Adadynski L, Wasiak D, et al. Etiological agents of bacteremia in the early period after liver transplantation. Transplant Proc. 2007;39(9):2816-21.
García-Prado E, Cordero E, María Álamo J, Ángel Gómez M, Manuel Pascasio J, Sánchez M, et al. Estudio descriptivo de las complicaciones infecciosas en 109 receptores de trasplantes hepáticos consecutivos. Enferm Infecc Microbiol Clin. 2009;27(4):199-205.
Losada I, Cuervas-mons V, Millán I, Dámaso D. Infección precoz en el paciente con 50 trasplante hepático : incidencia, gravedad, factores de riesgo y sensibilidad antibiótica de los aislados bacterianos. 2014;20(9):422-30.
Kim Y, Kim S, Wie S. Infectious complications in living-donor liver transplant recipients: A 9-year single-center experience. Transpl Infect Dis. 2008;10(5):316-24.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: El trasplante hepático ortotópico es la colocación de un nuevo hígado en la misma ubicación del explantado. El objetivo es prolongar la duración y la calidad de vida en pacientes con enfermedades hepáticas terminales. Sin embarg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d0e3058d4f37964b2c22e853906587
http://repository.urosario.edu.co/handle/10336/11842
http://repository.urosario.edu.co/handle/10336/11842
Autor:
Mantilla, William1,2 (AUTHOR) wmantilla@fctic.org, Gonzalez, Maríafernanda3 (AUTHOR), Rojas, Sebastián4 (AUTHOR), Borras-Osorio, Mariana2,5 (AUTHOR), Molano-Gonzalez, Nicolas6 (AUTHOR), Moran, Diego5,7 (AUTHOR), Guerra, Joaquín Hernando5,8,9 (AUTHOR), Romero, Oscar10 (AUTHOR), Munevar, Isabel2,5,9,11 (AUTHOR), Borda Molina, Andres Armando (AUTHOR), Preciado, Beatriz Elena (AUTHOR), Calidonio, Camila Lema (AUTHOR), Moran Ortiz, Diego Efrain (AUTHOR), Lopez, Isabel Munevar (AUTHOR), Guerra Villamizar, Joaquin Hernando (AUTHOR), Daza Buitrago, Jorge Anibal (AUTHOR), Osorio, Mariana Borras (AUTHOR), Lujan Piedrahita, Mauricio Humberto (AUTHOR), Medina, Mauricio Lema (AUTHOR), Mantilla Duran, William Armando (AUTHOR)
Publikováno v:
JCO Global Oncology. 12/1/2024, Vol. 10, p1-11. 11p.
